Psychiatric Disorders
Biohaven Pharmaceuticals Inc. is active in clinical research for Obsessive Compulsive Disorder, with studies centered on patients who have not responded adequately to standard SSRI and related antidepressant treatments.
- Obsessive Compulsive Disorder
- Treatment-resistant symptoms
- Adjunctive therapy
The sponsor’s psychiatric research includes evaluation of symptom improvement and longer-term safety and tolerability in individuals living with persistent compulsive and intrusive symptoms.
Neuromuscular Disease
Biohaven also supports research in Spinal Muscular Atrophy, focusing on functional outcomes in participants receiving established disease-modifying treatments such as nusinersen and risdiplam.
- Spinal Muscular Atrophy
- Motor function
- Neuromuscular impairment
These studies examine changes in physical performance and mobility-related measures in a chronic motor neuron disorder.
Central Nervous System Therapeutics
The sponsor’s portfolio reflects interest in central nervous system conditions where persistent symptoms affect daily functioning and quality of life, particularly in neuropsychiatric and neurologic disease settings.
- Neuropsychiatric disorders
- Neurologic disorders
- Functional outcome assessment
Research activity spans symptom control, functional change, and treatment response in disorders with substantial unmet medical need.
